Risk factor
High price volatility
Profitability factor
Overvalued vs peers
About
Porton Pharma Solutions Ltd. manufactures and supplies small molecule active pharmaceutical ingredients and drug intermediates, dosage forms, and biologics to the pharmaceutical companies. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. Porton Pharma Solutions Ltd. was founded in 2005 and is...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, trading a
Target Price
The average target price of 300363.SZ is 30 and suggests 25% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell